A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer TherapiesAstrid Zimmermann(Merck KGaA, Darmstadt (Germany)), Andree Blaukat(Merck KGaA, Darmstadt (Germany))Molecular Cancer TherapeuticsApril 11, 202210.1158/1535-7163.mct-21-0934Cited by 50SaveCiteExport RISWatch citationsRelated PapersPhosphorylation by casein kinase 2 induces PACS‐1 binding of nephrocystin and targeting to cilia|The EMBO Journal|2005|95The c-Met Inhibitor MSC2156119J Effectively Inhibits Tumor Growth in Liver Cancer Models|Cancers|2014|61